Health Canada inspection
Sanofi Genzyme, A Division of Sanofi-Aventis Canada Inc.: Health Canada inspection of Jan 31, 2022
Health Canada · GMP · rating C
Key facts
| Establishment | Sanofi Genzyme, A Division of Sanofi-Aventis Canada Inc. |
|---|---|
| City | Toronto |
| Province | Ontario |
| Country | Canada |
| Program | GMP |
| Start date | Jan 26, 2022 |
| End date | Jan 31, 2022 |
| Rating | C |
| Rating description | Compliant |
| Licence number | 100054 |
At a glance
- 1–9 Observations cited
- 1–9 Inspections of this establishment
- No Currently licensed
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Health Canada inspections
Health Canada inspects establishments that conduct licensable activities with drugs, including good manufacturing practices (GMP) and pharmacovigilance (GVP) inspections. Clinical trial (GCP) inspections, which name individuals, are not published here.